ClinicalTrials.Veeva

Menu

Optical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age) (OCTAC)

I

Insel Gruppe AG, University Hospital Bern

Status

Withdrawn

Conditions

Retinopathy of Prematurity
Diabetic Retinopathy

Treatments

Device: OCT-A

Study type

Observational

Funder types

Other

Identifiers

NCT03399825
OCTA children

Details and patient eligibility

About

Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases in children

Full description

Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA compares the decorrelation signal between sequential OCT b-scans taken at precisely the same cross-section in order to construct a map of blood flow. At present, level 1 evidence of the technology's clinical applications doesn't exist. The investigators plan to compare OCTA as an imaging modality to conventional imaging modalities used in clinical routine.

Sex

All

Ages

6 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients (children ≥ 6 <14 years of age) from the Childrens Hospital, University Hospital Bern requiring routine internal medical check-up for the diagnosis of diabetes or children attending routine eye exams at the department of ophthalmology, who are willing to participate in the study, and whos parents are willing to sign informed consent on behalf of their child.
  • Patients need to be at least 6 years of age (but younger than 14 years) 6 years of age or younger

Exclusion criteria

  • Patients (children) who are not willing or able to participate, or potential participant's parents who are not willing to sign informed consent on behalf of their child.
  • Patients younger than 6 years of age or 14 years or older.
  • Patients (children) with epilepsy

Trial design

0 participants in 3 patient groups

Healthy controls
Description:
Children without eye disease
Treatment:
Device: OCT-A
Retinopathy of prematurity (ROP)
Description:
Previously preterm children with a history of ROP
Treatment:
Device: OCT-A
Diabetic retinopathy
Description:
Children with diabetes
Treatment:
Device: OCT-A

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems